Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery

European Heart Journal

Volumn 36, Issue 40, 2015, Pages 2745-2753

  Kohler, Philipp ^a   Kuster, Stefan P ^a   Bloemberg, Guido ^b   Schulthess, Bettina ^b   Frank, Michelle ^a   Tanner, Felix C ^a   Rössle, Matthias ^a   Böni, Christian ^a   Falk, Volkmar ^a,c   Wilhelm, Markus J ^a   Sommerstein, Rami ^a   Achermann, Yvonne ^a   Oever, Jaap Ten ^d   Debast, Sylvia B ^e   Wolfhagen, Maurice J H M ^e   Bruinsma, George J Brandon Bravo ^e   Vos, Margreet C ^f   Bogers, Ad ^f   Serr, Annerose ^g   Beyersdorf, Friedhelm ^h   Sax, Hugo ^a   Böttger, Erik C ^b   Weber, Rainer ^a   Van Ingen, Jakko ^d   Wagner, Dirk ^g   Hasse, Barbara ^a   more..

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ISALA HOSPITAL   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF FREIBURG   (Germany)

^h UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Aortic graft infection; Cardiac surgery; Health care associated infection; Mycobacterium chimaera; Myocarditis; Prosthetic valve endocarditis

Indexed keywords

AMIKACIN; AZATHIOPRINE; AZITHROMYCIN; CLARITHROMYCIN; ETHAMBUTOL; METHOTREXATE; MOXIFLOXACIN; OFLOXACIN; RIFABUTIN; RIFAMPICIN; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; AORTA GRAFT; AORTIC VASCULAR GRAFT; ARTICLE; BACTERIAL STRAIN; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; GRAFT INFECTION; GRAFT REJECTION; HEALTHCARE ASSOCIATED INFECTION; HEART SURGERY; HEART VALVE PROSTHESIS; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MULTICENTER STUDY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM CHIMAERA; MYCOBACTERIUM CHIMAERA INFECTION; MYOCARDITIS; OPEN HEART SURGERY; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHESIS MATERIAL; PROSTHETIC VALVE ENDOCARDITIS; PULMONARY ARTERY; STEROID THERAPY; SURGICAL PATIENT; SURGICAL RISK; SYMPTOM; ADVERSE EFFECTS; AORTA VALVE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; INFANT; MEDICAL DEVICE CONTAMINATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PROSTHESIS-RELATED INFECTIONS; SURGERY;

ADULT; AGED; AORTIC VALVE; CORONARY ARTERY BYPASS; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; EQUIPMENT CONTAMINATION; FEMALE; HEART VALVE PROSTHESIS; HUMANS; INFANT; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PROSTHESIS-RELATED INFECTIONS;

EID: 84948684471     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv342     Document Type: Article

References (31)

1. Robicsek F, Daugherty HK, Cook JW, Selle JG, Masters TN, O'Bar PR, Fernandez CR, Mauney CU, Calhoun DM. Mycobacterium fortuitum epidemics after open-heart surgery. J Thoracic Cardiovasc Surg 1978;75:91-96.
2. Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ Jr. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Int Med 1983;98:938-939.
3. Strabelli TM, Siciliano RF, Castelli JB, Demarchi LM, Leao SC, Viana-Niero C, Miyashiro K, Sampaio RO, Grinberg M, Uip DE. Mycobacterium chelonae valve endocarditis resulting from contaminated biological prostheses. J Infect 2010;60:467-473.
4. Vukovic D, Parezanovic V, Savic B, Dakic I, Laban-Nestorovic S, Ilic S, Cirkovic I, Stepanovic S. Mycobacterium fortuitum endocarditis associated with cardiac surgery, Serbia. Emerg Infect Dis 2013;19:517-519.
5. Jonsson G, Rydberg J, Sturegard E, Christensson B. A case of Mycobacterium goodii prosthetic valve endocarditis in a non-immunocompromised patient: use of 16S rDNA analysis for rapid diagnosis. BMC Infect Dis 2012;12:301.
6. Bush LM, Paturi A, Chaparro-Rojas F, Perez MT. Mycobacterial prosthetic valve endocarditis. Curr Infect Dis Rep 2010;12:257-265.
7. Achermann Y, Rossle M, Hoffmann M, Deggim V, Kuster S, Zimmermann DR, Bloemberg G, Hombach M, Hasse B. Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera. J Clin Microbiol 2013;51:1769-1773.
8. Tortoli E, Rindi L, Garcia MJ, Chiaradonna P, Dei R, Garzelli C, Kroppenstedt RM, Lari N, Mattei R, Mariottini A, Mazzarelli G, Murcia MI, Nanetti A, Piccoli P, Scarparo C. Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol 2004;54(Pt 4):1277-1285.
9. Wallace RJ Jr, Iakhiaeva E, Williams MD, Brown-Elliott BA, Vasireddy S, Vasireddy R, Lande L, Peterson DD, Sawicki J, Kwait R, Tichenor WS, Turenne C, Falkinham JO 3rd. Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease. J Clin Microbiol 2013;51:1747-1752.
10. Nagpal A, Wentink JE, Berbari EF, Aronhalt KC, Wright AJ, Krageschmidt DA, Wengenack NL, Thompson RL, Tosh PK. A cluster of Mycobacterium wolinskyi surgical site infections at an Academic Medical Center. Infect Control Hosp Epidemiol 2014;35:1169-1175.
11. Sax H, Bloemberg G, Hasse B, Sommerstein R, Kohler P, Achermann Y, Rossle M, Falk V, Kuster SP, Bottger EC, Weber R. Prolonged outbreak of Mycobacterium chimaera infection after open chest heart surgery. Clin Infect Dis 2015;61:67-75.
12. Massnahmen für höhere Patientensicherheit in der Herzchirurgie. Bundesamt für Gesundheit. https://www.news.admin. ch/message/index.html?lang= de&msg-id=53774 (14 July 2014).
13. Investigation of Mycobacterium chimaera infection associated with cardiopulmonary bypass. Public Health England. https://www.gov.uk/government/publications/health-protection-report-volume-9-2015/hpr-volume-9-issue-15-news-30-april (19 May 2015).
14. Risk assessment on Mycobacterium chimaera infections associated with heatercooler units. ECDC. http://ecdc.europa.eu/en/publications/Publications/mycobacterium-chimaera-infection-associated-with-heater-coolerunitsrapid-risk-assessment-30-April-2015.pdf (19 May 2015).
15. Peter-Getzlaff S, Luthy J, Voit A, Bloemberg GV, Bottger EC. Detection and identification of Mycobacterium spp. in clinical specimens by combining the Roche Cobas Amplicor Mycobacterium tuberculosis assay with Mycobacterium genus detection and nucleic acid sequencing. J Clin Microbiol 2010;48:3943-3948.
16. Hombach M, Somoskovi A, Homke R, Ritter C, Bottger EC. Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST. Int J Med Microbiol 2013;303:270-276.
17. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
19. M. S. Grading of patients for surgical procedures. Anesthesiology 1941;2:281-284.
20. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638.
21. Investigation of Mycobacterium chimaera infection associated with cardiopulmonary bypass: an update. Public Health England. https://www.gov.uk/government/publications/health-protection-report-volume-9-2015/hpr-news-volume-9-issue-18-21-may (21 May 2015).
22. Hartcentra nemen maatregelen om hartoperaties veiliger te maken. Inspectie voor de Gezondheitsvorg. http://www.igz.nl/actueel/nieuws/hartcentra-nemen-maatregelen-om-hartoperaties-veiliger-te-maken. aspx (25 June 2015).
23. Problematik kardiovaskulärer Infektionen durch Mykobakterium chimaera im Zusammenhang mit Heater-Cooler-Systemen bei Herzoperationen. http://www.bfarm.de/SharedDocs/Risikoinformationen/Medizinprodukte/DE/Hypothermiegeraete.html?nn53495464. Bundesinstitut für Arzneimittel und Medizinprodukte (10 July 2015).
24. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004;350:1422-1429.
25. Clinical and Laboratory Standards Institute (CLSI). 2003. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved standard. CLSI document M24-A.
26. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Committee on Rheumatic Fever E, Kawasaki D, Council on Cardiovascular Disease in the Y, Councils on Clinical Cardiology S, Cardiovascular S, Anesthesia, American Heart A, Infectious Diseases Society of A. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-e434.
27. van Ingen J, Egelund EF, Levin A, Totten SE, Boeree MJ, Mouton JW, Aarnoutse RE, Heifets LB, Peloquin CA, Daley CL. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. Am J Respir Crit Care Med 2012;186:559-565.
28. Koh WJ, Jeong BH, Jeon K, Lee SY, Shin SJ. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012;186:797-802.
29. Frei E, Hodgkiss-Harlow K, Rossi PJ, Edmiston CE Jr, Bandyk DF. Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection. Vasc Endovasc Surg 2011;45:688-696.
30. Epidemiological update: invasive infections with Mycobacterium chimaera potentially associated with heater-cooler units used during cardiac surgery. ECDC. http://ecdc.europa.eu/en/press/news/-layouts/forms/News-DispForm.aspx?ID=1223&List=8db7286c-fe2d-476c-9133-18ff4cb1b568&Source=http% 3A%2F%2Fecdc.europa.eu%2Fen%2Fpress%2Fnews%2FPages%2FNews.aspx (22 May 2015).
31. Protocol for case detection, laboratory diagnosis and environmental testing of Mycobacterium chimaera infections potentially associated with heater-cooler units. ECDC. http://ecdc.europa.eu/en/activities/diseaseprogrammes/ARHAI/Pages/about-programme.aspxEU.